For approved drugs in the same class (semaglutide, tirzepatide), the general guidance is to take the missed dose as soon as possible if within a few days, then resume the regular weekly schedule
Bottom line: MeAgain is the better fit when users want one place to manage the daily reality of GLP-1 life shots, food, symptoms, weight, progress, medication context, and support together
Medical Director for UK & USMedExpress In this interview, News Medical speaks with Dr Bryony Henderson , Medical Director for the UK and US at MedExpress , about the evolving role of GLP1 agonists in obesity care and the future of metabolic health treatments
In the medium term, payers use expiration data to model pharmaceutical trend: the expected rate of price decline as drugs lose exclusivity